Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Microbiological Methods|May 12, 2009
Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfacesDavid A Coleman, Soon-Hwan Oh, Xiaomin Zhao, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditisJohn Vernachio, Arnold S Bayer, Thuan Le, et al.
Hybridoma (2005)|February 24, 2007
A panel of monoclonal antibodies recognizing the Staphylococcus epidermidis fibrinogen-binding MSCRAMM SdrGAndrea E Hall, Pratiksha R Patel, Paul J Domanski, et al.
Microbial Pathogenesis|May 25, 2007
Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: conditional expression and binding analysisAndrea E Hall, Elena L Gorovits, Peter J Syribeys, et al.
FEMS Immunology and Medical Microbiology|January 22, 2011
Antibody response to the extracellular adherence protein (Eap) of Staphylococcus aureus in healthy and infected individualsInsa Joost, Susanne Jacob, Olaf Utermöhlen, et al.
Infection and Immunity|November 26, 2003
Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor AAndrea E Hall, Paul J Domanski, Pratiksha R Patel, et al.
Infection and Immunity|July 26, 2005
Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureusPaul J Domanski, Pratiksha R Patel, Arnold S Bayer, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virusChristopher McGuigan, Karolina Madela, Mohamed Aljarah, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaJ John Weems, James P Steinberg, Scott Filler, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
INX-08189, a phosphoramidate prodrug of 6-O-methyl-2'-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic propertiesJohn H Vernachio, Blair Bleiman, K Dawn Bryant, et al.
Pageof 2